Advertisement

Topics

NCE Discovery Limited Company Profile

16:45 EDT 20th September 2018 | BioPortfolio

nce discovery was spun out of the Wolfson Institute for Biomedical Research, University College London in 2001 and provides expert medicinal chemistry services to pharmaceutical and biotechnology companies across the UK and Europe. Our state of the art laboratories are based in Cambridge, UK, at the centre of Europe’s largest biotechnology cluster.nce discovery builds a full understanding of the client’s needs, and the technical challenges presented by biological targets of interest. The Company can support and design comprehensive chemistry programmes – from hit finding through to pre-clinical development. These programmes are designed and delivered by experienced medicinal chemists working in fully equipped laboratories, supported by expert computational chemistry using industry-leading software.

Location

418 Cambridge Science Park Milton Road
Cambridge
Cambridgeshire
CB4 0PZ
United Kingdom

Contact

Phone: 44 (0)1993 201 801
Fax: 44 (0)1993 200 401
Email: info@ncediscovery.com


News Articles [328 Associated News Articles listed on BioPortfolio]

Integrated lead discovery: An evolving toolbox

(SLAS (Society for Laboratory Automation and Screening)) A new SLAS Discovery review article by GlaxoSmithKline researchers in the US and UK offers an informative guide to the established and emerging...

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

High-Throughput Flow Cytometry in Drug Discovery

NewsA new special issue of SLAS Discovery reflects examples of the recent groundswell of creative new applications for high-throughput flow cytometry (HTFC) in drug discovery.

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

The Current issue of “The view from here” is concerned with nanoscience in drug discovery.

The topic of this month’s newsletter from Drug Discovery Today is “nanoscience in drug discovery”

The Current issue of “The view from here” is concerned with Allosterism in Drug Discovery.

The topic of this month’s newsletter from Drug Discovery Today is “Allosterism in Drug Discovery”.

Planck’s Law: A nanoscale discovery with big implications

A recent discovery by William & Mary and University of Michigan researchers transforms our understanding of one of the most important laws of modern physics. The discovery, published in the journa...

PubMed Articles [473 Associated PubMed Articles listed on BioPortfolio]

Translation of innovative chemistry into screening libraries: an exemplar partnership from the European Lead Factory.

The identification of high-quality starting points for drug discovery is an enduring challenge in medicinal chemistry. Yet, the chemical space explored in discovery programmes tends be limited by the ...

The continuing effect of the discovery of IgE by Kimishige Ishizaka.

Sadly, Kimi Ishizaka died on July 6, 2018. I would like to take the opportunity to consider his role in the discovery of IgE and the effect of that discovery. All of us owe an enormous debt to those w...

Filling the drug discovery gap: is high-content screening the missing link?

In recent years, questions about the sustainability of the current drug discovery process have triggered a revival of interest in phenotypic drug discovery approaches. This trend has clearly been ampl...

Computational Toxicology and Drug Discovery.

The use of computational toxicology methods within drug discovery began in the early 2000s with applications such as predicting bacterial mutagenicity and hERG inhibition. The field has been continuou...

Challenges with biomarkers in cancer drug discovery and development.

Clinical Trials [179 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [1181 Associated Companies listed on BioPortfolio]

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Sentinel Oncology Limited

Sentinel Oncology was founded in 2005 with the vision of developing an innovative strategy for cancer treatment, ‘Targeted Synergy’ in which a single drug can be engineered to deliver tw...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including www.discoveryhealth.com, as well as its Continuing Medical Education (CME) business and ...

More Information about "NCE Discovery Limited" on BioPortfolio

We have published hundreds of NCE Discovery Limited news stories on BioPortfolio along with dozens of NCE Discovery Limited Clinical Trials and PubMed Articles about NCE Discovery Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NCE Discovery Limited Companies in our database. You can also find out about relevant NCE Discovery Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record